Beijing Honglin Pharma. Co., Ltd.

中文

CN

中文 English

Product Center

NSAIDs

JUPOPINE^®
Nifedipine Controlled-release Tablets

JUPOSHU^®
Amlodipine Besylate Tablets

JUPOKE^®
Enalapril Maleate and Hydrochlorothiazide Tablets (Ⅰ)

Detrilin^®
Isosorbide Mononitrate Sustained-release Capsules (II)

RoToFier^®
Glipizide Extended Release Tablets

JUPOCIN^®
Indometacin Sustained-release Capsules

JUPOPHON^®
Ibuprofen Sustained-release Capsules

Kelanmei
Lansoprazole Enteric Capsules

HOWELT^®
Famotidine, Calcium Carbonated and Magnesium Hydroxide Chewable Tablets

ROTECON^®
Reboxetine Mesylate Tablets

JUPOTON^®
Loratadine and Pseudoephedrine Sulfate Sustained Release Tablets

JUPOPINE^®
Nifedipine Controlled-release Tablets

JUPOSHU^®
Amlodipine Besylate Tablets

JUPOKE^®
Enalapril Maleate and Hydrochlorothiazide Tablets (Ⅰ)

Detrilin^®
Isosorbide Mononitrate Sustained-release Capsules (II)

RoToFier^®
Glipizide Extended Release Tablets

Kelanmei
Lansoprazole Enteric Capsules

HOWELT^®
Famotidine, Calcium Carbonated and Magnesium Hydroxide Chewable Tablets

JUPOCIN^®
Indometacin Sustained-release Capsules

JUPOPHON^®
Ibuprofen Sustained-release Capsules

ROTECON^®
Reboxetine Mesylate Tablets

JUPOTON^®
Loratadine and Pseudoephedrine Sulfate Sustained Release Tablets

Latest News

NEWS

2022/0402

Grand Opening of Beijing Honglin Pharmaceutical CBD Office

2022/0127

JUPOPHON^® Ibuprofen Sustained-release Capsules Got the Consistency Evaluation Certified

2021/0926

VIPs of the Huairou District Political Consultative Conference and Huairou District Health Commission Visited Beijing Honglin

2021 官网升级中！现在您访问官网的浏览器设备分辨率宽度低于1280px
请使用高分辨率宽度访问。